t

to-BBB

14 employees

The Company combines existing drugs with to-BBB’s proprietary G-Technology® for enhanced drug delivery across the blood-brain barrier.

Basic info

Industry

biotechnology research

Sectors

blood-brain barrier
Biotechnology
neuroinflammation
brain cancer
Pharmaceutical
drug delivery
Biopharma

Date founded

2003

Funding rounds raised

Total raised

$5.5M

from 3 investors over 3 rounds

t

to-BBB raised $5.5M on February 3, 2011

Investors: Antea Participaties and Aescap

t

to-BBB raised $5.4M on July 6, 2007

Investors: Aescap

FAQ